Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing WASHINGTON, June 20, 2016 (GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the...

American College of Rheumatology Rolls Out Lupus Education for Providers & Patients in more than 25 States Nationwide ATLANTA, Oct. 28, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) has awarded the American College of Rheumatology's (ACR) The Lupus Initiative (TLI) with a five-year...

Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting BETHLEHEM, Pa., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Levolta Pharmaceuticals, Inc. today presented the results of an exploratory Phase II study for a potential disease modifying drug for patients with...

The Lupus Initiative Unveils Free Curriculum and Education Materials to Advance Care for Patients Fighting Devastating Autoimmune Disease WASHINGTON, May 16, 2013 (GLOBE NEWSWIRE) -- The Lupus Initiative, a national provider education program led by the American College of Rheumatology, today announced a new easy-to-use curriculum and...